Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
AZTherapies logo — Targeting Neuroinflammation: The Common Thread of Neurodegen...

AZTherapies

Targeting Neuroinflammation: The Common Thread of Neurodegenerative Disease Progression

Founded 2011 United States Boston, United States 10 employees Venture round Total: $99.84M Biopharma, Biotechnology +3

General Information

Company Name AZTherapies
Founded Year 2011
Location United States Boston, United States
Employees 10
Industries Biopharma, Biotechnology, Health Care +2
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with AZTherapies. To contact AZTherapies, visit aztherapies.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does AZTherapies compare?

A PDF of AZTherapies and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting AZTherapies soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About AZTherapies

AZTherapies is a late-stage clinical biopharmaceutical company founded in 2011, with the slogan "Targeting Neuroinflammation: The Common Thread of Neurodegenerative Disease Progression". The company is based in the United States and operates within the industries of Biopharma, Biotechnology, Health Care, and Pharmaceutical. AZTherapies is focused on developing treatments for neurological conditions by addressing neuro-inflammation as a root cause of neuro-degeneration. Their innovative approach involves leveraging the potential of cromolyn, a small molecule, to shift the brain’s innate immune cells from a pro-inflammatory to neuroprotective state. The company's pipeline includes candidates for Alzheimer's Disease, amyotrophic lateral sclerosis (ALS), and post-ischemic stroke cognitive impairment. In their most recent funding round on 14 September 2020, AZTherapies secured $14.83M in a Venture Round investment, with the Catalytic Impact Foundation participating as the investor. The focus on addressing neuro-inflammatory aspects of neurodegenerative diseases, coupled with a promising pipeline, positions AZTherapies as a key player in the biopharmaceutical space, attracting the support of impactful investors. As the company progresses in its mission to develop effective treatments for devastating neurological conditions, its innovative multi-modal approach and promising developments make AZTherapies a compelling prospect for potential investors in the healthcare and biopharma sectors.

Business keywords: Neuroinflammation, Neurodegenerative Disease, Clinical Biopharmaceutical, Innovative Treatment, Cromolyn, Alzheimer's Disease, Amyotrophic Lateral Sclerosis, Stroke Cognitive Impairment, Late-Stage Clinical, Neuroprotective, Small Molecule Therapies, Biopharmaceutical, Neurological Conditions, Innate Immune Cells, Safety Profile

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $14.83M 1
Catalytic Impact Foundation
Catalytic Impact Foundation
14 Sep 2020
Series C $26.30M 5
DRADS Capital
DRADS Capital, Wexford Capital +3
17 Oct 2019
Series B $23.79M 1
Cosine
18 Jun 2018
Convertible Note $1.57M -
01 Dec 2017
Convertible Note $6.55M -
01 Jun 2017
Series A $16.50M 1
IBS Capital
20 Nov 2015
Venture Round $6.11M -
05 Jan 2015
Seed Round $4.20M -
30 Apr 2012

AZTherapies Alternatives & Competitors

View All Alternatives
AZTherapies vs
Therini Bio, Inc.
Therini Bio, Inc. United States

A new approach to block vascular-mediated inflammation

Series A
15 employees
Biotechnology, Health Care
AZTherapies vs
Jupiter Neurosciences, Inc.
Jupiter Neurosciences, Inc. United States

A clinical-stage drug platform company focused on treating neuroinflammation.

Private Equity
6 employees
Biotechnology, Pharmaceutical
AZTherapies vs
Cytokinetics
Cytokinetics United States

Empowering Muscle Empowering Lives

IPO
779 employees
Biopharma, Biotechnology
View all alternatives

FAQ About AZTherapies

Targeting Neuroinflammation: The Common Thread of Neurodegenerative Disease Progression
AZTherapies was founded in 2011.
AZTherapies is headquartered in Boston, United States.
AZTherapies operates in Biopharma, Biotechnology, Health Care, Health and Wellness and Pharmaceutical. Its work centres on Neuroinflammation, Neurodegenerative Disease, Clinical Biopharmaceutical and Innovative Treatment.
AZTherapies has approximately 10 employees.
AZTherapies has completed 8 funding rounds, raising a total of $99.84M. The latest funding stage is Venture round.
Top alternatives and competitors to AZTherapies include Therini Bio, Inc., Jupiter Neurosciences, Inc., Cytokinetics, ESCAPE Bio, Allyx Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
AZTherapies and Therini Bio, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for AZTherapies, https://bouncewatch.com/company/aztherapies, updated 28 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes